Stereotaxis Inc. (STXS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Stereotaxis Inc., updated every trading day.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus
Price
$0.97
−5.80% today
Market cap
$103M
Overall quality
—
Kronos AI 30-day
+42.0%
8 of 8 simulated paths end higher
Stereotaxis Inc. (STXS) is a Health Care company in Biotechnology: Electromedical & Electrotherapeutic Apparatus, worth $103M. It trades at $0.97, down 5.80% today. 3 analysts' average target of $3.00 implies +209.3% from today's price. Kronos AI's 30-day forecast is +42.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.00 |
| Low – high | $3.00 – $3.00 |
| Analysts | 3 |
| Upside to average | +209.3% |
Kronos AI 30-day forecast
| Expected close | $1.46 (+42.0%) |
| Likely range | +38.3% … +54.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Electromedical & Electrotherapeutic Apparatus
For information only, not investment advice. Prices updated: 2026-10-29.